Product Name: Complete Configuration – Modular Peptide Systems A+B+C+D+E Configuration Classification: Full Modular Framework Product Information:

• Configuration Type: Complete Multi-Modular Peptide Framework
• Included Modules: A, B, C, D, E
• Total Modules: 5
• System Compatibility: Full Topical System Architecture
• Testing Methodology: HPLC-UV-MS
• Analytical Verification: ISO/IEC 17025 Accredited Laboratory
• Evaluation Format: Individual Module, Configuration-Based, or Full-System Comparative Evaluation

Analytical Composition: Module A

• Total Peptide Content: 0.10%
• Palmitoyl Tripeptide-1
• Palmitoyl Tetrapeptide-7

Module B

• Total Peptide Content: 0.23%
• Palmitoyl Tripeptide-38
• Palmitoyl Tetrapeptide-7

Module C

• Total Peptide Content: 0.52%
• Dipeptide-2
• Acetyl Tetrapeptide-5
• Palmitoyl Tetrapeptide-7
• Plus 0.30% Caffeine

Module D

• Total Peptide Content: 0.10%
• AHK-Cu
• Plus 0.20% Tocopherol (Vitamin E)

Module E

• Total Peptide Content: 0.13%
• Acetyl Octapeptide-3 (SNAP-8)
• Tetrapeptide-21
• AHK-Cu

Cumulative Analytical Breadth

• Eight distinct peptides
• Five structural peptide classes
• Two non-peptide supporting components
• Four formulation architectures

Product Description: The Complete Configuration is one of three configurations within PHP’s Modular Peptide System, a modular framework of peptide formulations designed for research evaluation. Configurations represent defined combinations of individual modules (A through E) assembled to provide broader comparative frameworks than standalone module evaluation. The Complete Configuration combines all five modules within a single integrated framework, representing the full compositional and chemistry-class breadth of the Topical System. By incorporating foundational, targeted, localized, advanced, and composite compositions, the Complete Configuration provides access to every formulation architecture available within the modular platform. Each included module is independently verified through ISO/IEC 17025-accredited analytical testing using HPLC-UV-MS methodology. Batch-specific Certificates of Analysis are available through the COA-Topicals library. Research Framework:

• Complete Topical System architecture
• All five modules in a single configuration
• Eight peptides across five structural classes
• Broadest analytical diversity within the platform
• Includes every formulation type utilized throughout the system

The Complete Configuration supports multiple evaluation approaches, including individual module evaluation, configuration-based evaluation, and sequential configuration evaluation within a 24-hour cycle. When Phase 1 and Phase 2 are sequenced together, defined separation intervals (typically ~12 hours) between configurations allow the analytical contributions of each to be observed without compositional overlap. Configuration Characteristics:

• Combines all foundational, concentrated, precision, advanced, and composite modules
• Incorporates both free peptides and copper-coordinated peptide complexes
• Includes serum-emulsion, gel, low-viscosity emulsion, and buffered copper-peptide matrices
• Represents the broadest concentration range within the platform
• Includes both single-peptide-dominant and multi-peptide composite formulations
• Provides access to every major compositional variable engineered into the Modular Peptide System

Position Within The System: Within the Modular Peptide System framework, the Complete Configuration represents the full modular architecture. It integrates all five modules into a single structured platform and encompasses the entire range of compositional variables the system was designed to evaluate, including peptide structural class, peptide concentration, formulation complexity, chemistry class, and delivery matrix. Unlike Phase 1 and Phase 2, which isolate specific portions of the modular framework, the Complete Configuration provides access to the full comparative breadth of the system. It represents the highest level of compositional diversity available within the Topical System platform. System Architecture: The Complete Configuration spans the principal formulation variables incorporated throughout the Topical System:

• Peptide Structural Classes: Palmitoylated, Dipeptide, Acetylated Tetrapeptide, Acetylated Octapeptide, Tetrapeptide, Copper-Coordinated Peptide
• Concentration Range: 0.10% to 0.52% total peptide content
• Composition Complexity: Single-peptide-dominant through multi-peptide composite architectures
• Delivery Matrices: Serum-Emulsion, Gel, Controlled-Rheology Emulsion, Buffered Copper-Peptide Serum
• Supporting Components: Caffeine and Tocopherol

Together, these variables establish the broadest analytical and compositional framework available within the modular system. Configuration Specifications:

• Included Modules: A + B + C + D + E
• Total Modules: 5
• Total Peptides: 8
• Structural Classes: 5+
• Supporting Components: Caffeine, Tocopherol
• Formulation Architectures: 4
• Verification: ISO/IEC 17025 HPLC-UV-MS
• Packaging: Opaque Airless UV-Protective Packaging
• COA Availability: Batch-Specific Certificates of Analysis

Analytical Verification: Each module within the Complete Configuration is independently verified through ISO/IEC 17025-accredited analytical testing utilizing HPLC-UV-MS methodology. Batch-specific Certificates of Analysis are available through the COA-Topicals library. All included formulations are housed in opaque, airless, light-protective packaging designed to support compositional integrity throughout storage and evaluation. Compliance Notice: The Complete Configuration is FOR RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE. This product is not a drug, cosmetic, food, or dietary supplement and has not been evaluated or approved by the U.S. Food and Drug Administration. It is intended solely for lawful in vitro research and not for any human or animal use. By purchasing this product, buyer represents and warrants that it will be used exclusively for lawful in vitro research in compliance with all applicable laws and regulations, and assumes all responsibility for any use inconsistent with this notice.